155 related articles for article (PubMed ID: 31054253)
41. Mitochondrial DNA levels in blood and tissue samples from breast cancer patients of different stages.
Xia P; Wang HJ; Geng TT; Xun XJ; Zhou WJ; Jin TB; Chen C
Asian Pac J Cancer Prev; 2014; 15(3):1339-44. PubMed ID: 24606462
[TBL] [Abstract][Full Text] [Related]
42. A circulating miRNA signature as a diagnostic biomarker for non-invasive early detection of breast cancer.
Zhang L; Xu Y; Jin X; Wang Z; Wu Y; Zhao D; Chen G; Li D; Wang X; Cao H; Xie Y; Liang Z
Breast Cancer Res Treat; 2015 Nov; 154(2):423-34. PubMed ID: 26476723
[TBL] [Abstract][Full Text] [Related]
43. Circulating miR-205: a promising biomarker for the detection and prognosis evaluation of bladder cancer.
Fang Z; Dai W; Wang X; Chen W; Shen C; Ye G; Li L
Tumour Biol; 2016 Jun; 37(6):8075-82. PubMed ID: 26715266
[TBL] [Abstract][Full Text] [Related]
44. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
[TBL] [Abstract][Full Text] [Related]
45. Vitronectin: a promising breast cancer serum biomarker for early diagnosis of breast cancer in patients.
Hao W; Zhang X; Xiu B; Yang X; Hu S; Liu Z; Duan C; Jin S; Ying X; Zhao Y; Han X; Hao X; Fan Y; Johnson H; Meng D; Persson JL; Zhang H; Feng X; Huang Y
Tumour Biol; 2016 Jul; 37(7):8909-16. PubMed ID: 26753956
[TBL] [Abstract][Full Text] [Related]
46. Circulating long non-coding RNA AFAP1-AS1 is a potential diagnostic biomarker for non-small cell lung cancer.
Li W; Li N; Kang X; Shi K
Clin Chim Acta; 2017 Dec; 475():152-156. PubMed ID: 29080690
[TBL] [Abstract][Full Text] [Related]
47. Relationship between erb-B2 mRNA Expression in Blood and Tissue of Invasive Ductal Carcinoma Breast Cancer Patients and Clinicopathological Characteristics of the Tumors.
Moazzezy N; Ebrahimi F; Sisakht MM; Yahyazadeh H; Bouzari S; Oloomi M
Asian Pac J Cancer Prev; 2016; 17(1):249-54. PubMed ID: 26838218
[TBL] [Abstract][Full Text] [Related]
48. Investigation of MicroRNA-21 Expression Levels in Serum and Stool as a Potential Non-Invasive Biomarker for Diagnosis of Colorectal Cancer.
Bastaminejad S; Taherikalani M; Ghanbari R; Akbari A; Shabab N; Saidijam M
Iran Biomed J; 2017 Mar; 21(2):106-13. PubMed ID: 27432735
[TBL] [Abstract][Full Text] [Related]
49. Serum microRNA-21 expression as a prognostic and therapeutic biomarker for breast cancer patients.
Yadav P; Mirza M; Nandi K; Jain SK; Kaza RC; Khurana N; Ray PC; Saxena A
Tumour Biol; 2016 Nov; 37(11):15275-15282. PubMed ID: 27696295
[TBL] [Abstract][Full Text] [Related]
50. Candidate early detection protein biomarkers for ER+/PR+ invasive ductal breast carcinoma identified using pre-clinical plasma from the WHI observational study.
Buas MF; Rho JH; Chai X; Zhang Y; Lampe PD; Li CI
Breast Cancer Res Treat; 2015 Sep; 153(2):445-54. PubMed ID: 26319120
[TBL] [Abstract][Full Text] [Related]
51. Assessment of circulating HISLA as a potential biomarker for breast cancer diagnosis and prognosis.
Hu H; Hu J; Yang Y; Zhou W; Ye C
Clin Exp Med; 2021 Feb; 21(1):29-34. PubMed ID: 33123839
[TBL] [Abstract][Full Text] [Related]
52. Histological growth pattern of and alpha-actinin-4 expression in thyroid cancer.
Tanaka N; Yamashita T; Yamamoto S; Matsunobu T; Tsuda H; Honda K; Yamada T; Tamai S; Shiotani A
Anticancer Res; 2014 Jun; 34(6):3157-63. PubMed ID: 24922688
[TBL] [Abstract][Full Text] [Related]
53. The conglomeration of diagnostic, prognostic and therapeutic potential of serum miR-199a and its association with clinicopathological features in epithelial ovarian cancer.
Zuberi M; Khan I; Gandhi G; Ray PC; Saxena A
Tumour Biol; 2016 Aug; 37(8):11259-66. PubMed ID: 26951510
[TBL] [Abstract][Full Text] [Related]
54. ACTN4 copy number increase as a predictive biomarker for chemoradiotherapy of locally advanced pancreatic cancer.
Watanabe T; Ueno H; Watabe Y; Hiraoka N; Morizane C; Itami J; Okusaka T; Miura N; Kakizaki T; Kakuya T; Kamita M; Tsuchida A; Nagakawa Y; Wilber H; Yamada T; Honda K
Br J Cancer; 2015 Feb; 112(4):704-13. PubMed ID: 25602965
[TBL] [Abstract][Full Text] [Related]
55. Focal and segmental glomerulosclerosis in mice with podocyte-specific expression of mutant alpha-actinin-4.
Michaud JL; Lemieux LI; Dubé M; Vanderhyden BC; Robertson SJ; Kennedy CR
J Am Soc Nephrol; 2003 May; 14(5):1200-11. PubMed ID: 12707390
[TBL] [Abstract][Full Text] [Related]
56. Predicting axillary sentinel node status in patients with primary breast cancer.
Kolarik D; Pecha V; Skovajsova M; Zahumensky J; Trnkova M; Petruzelka L; Halaska M; Sottner O; Otcenasek M; Kolarova H
Neoplasma; 2013; 60(3):334-42. PubMed ID: 23374005
[TBL] [Abstract][Full Text] [Related]
57. Serum HOTAIR as a novel diagnostic biomarker for esophageal squamous cell carcinoma.
Wang W; He X; Zheng Z; Ma X; Hu X; Wu D; Wang M
Mol Cancer; 2017 Apr; 16(1):75. PubMed ID: 28376832
[TBL] [Abstract][Full Text] [Related]
58. [Serum miR-103 as a potential diagnostic biomarker for breast cancer].
Wang X; Wu X; Yan L; Shao J
Nan Fang Yi Ke Da Xue Xue Bao; 2012 May; 32(5):631-4. PubMed ID: 22588912
[TBL] [Abstract][Full Text] [Related]
59. Investigation of microRNA-155 as a serum diagnostic and prognostic biomarker for colorectal cancer.
Lv ZC; Fan YS; Chen HB; Zhao DW
Tumour Biol; 2015 Mar; 36(3):1619-25. PubMed ID: 25528214
[TBL] [Abstract][Full Text] [Related]
60. Study on the relationship between miR-520g and the development of breast cancer.
Ren GB; Wang L; Zhang FH; Meng XR; Mao ZP
Eur Rev Med Pharmacol Sci; 2016; 20(4):657-63. PubMed ID: 26957267
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]